Draft:Premom

From Wikipedia, the free encyclopedia

Premom is a fertility tracking and menstrual cycle management mobile application developed by Easy Healthcare Corporation, an Illinois-based company. The app was launched in 2017 and provides cycle tracking, ovulation prediction, and pregnancy monitoring.[1] The app operates on a freemium model and integrates with physical fertility testing products sold by Easy Healthcare.

  • Comment: Only the two WaPo articles (hence, one source) seem to provide significant coverage of this app, and that's not enough to establish notability per WP:GNG. DoubleGrazing (talk) 10:11, 31 December 2025 (UTC)

DeveloperEasy Healthcare Corporation
Initial release2017 (2017)
Quick facts Premom, Developer ...
Premom
DeveloperEasy Healthcare Corporation
Initial release2017 (2017)
Operating systemiOS, Android
PlatformMobile app
Available inEnglish, Chinese, Spanish, Portuguese
TypeHealth, Fertility tracking
LicenseFreemium
Websitepremom.com
Close

The company has faced regulatory scrutiny over its data privacy practices. This led to a temporary removal from the Google Play Store in 2020 following an IDAC investigation and a 2023 settlement with the Federal Trade Commission (FTC) regarding data sharing practices.

History

Easy Healthcare Corporation was founded by Sherry Liu and Li Zou in 2013.[2] The company initially sold ovulation test strips under the Easy@Home brand through e-commerce channels, including Amazon and Walmart, before launching the Premom app in 2017.[3] Premom was developed internally by Easy Healthcare and did not seek external venture capital funding. The company generates revenue through both app subscriptions and e-commerce sales of fertility testing products.

In 2018, the app added a digital test strip reader that lets users photograph ovulation test strips for automated analysis using image recognition technology.

Features

Premom tracks menstrual cycles, predicts ovulation, and monitors basal body temperature.[3] Users can photograph ovulation test strips, and the app analyzes them digitally. The app works with Easy Healthcare's physical products including ovulation test strips and basal thermometers.

The app is free to download with basic features available at no cost. Premium subscriptions unlock additional functionality.

Privacy controversies

Premom has been involved in several privacy-related incidents that drew regulatory attention and media coverage.

2020 removal from Google Play

In August 2020, the International Digital Accountability Council (IDAC) raised privacy concerns about Premom, leading Google Play to temporarily remove the app on August 6, 2020. Google restored the app the following day after Easy Healthcare made changes to its data practices.

Washington Post investigation

Later in August 2020, The Washington Post published an investigation based on IDAC's findings.[4] The report found that Premom shared user data with three Chinese advertising technology firms: Jiguang, Umeng, and UMSNS. IDAC's investigation found the app collected device identifiers, location data, and information about other installed apps. While researchers found no evidence that health data specifically was transmitted to third parties, IDAC president Quentin Palfrey said the data collection was "particularly concerning when we see this behavior with respect to an app that's targeted at women trying to become pregnant."[5]

Following the publication, Easy Healthcare stated it would discontinue data sharing with Jiguang and confirmed the company's access had been revoked. The company stated it was committed to compliance with global data privacy laws.

FTC settlement

In May 2023, the Federal Trade Commission and attorneys general from Connecticut, Oregon, and the District of Columbia announced a settlement with Easy Healthcare Corporation.[6] The investigation focused on data sharing practices between 2018 and 2020.

Easy Healthcare agreed to pay $200,000 in penalties and implement enhanced data security measures, including encryption and user consent requirements for data sharing.[6] The company described the settlement as "not an admission of any wrongdoing" and stated: "Protecting user data is a top priority."[6]

The regulatory actions against Premom occurred during a period of increased scrutiny over reproductive health data privacy in the United States, following similar settlements involving other fertility apps such as Flo and Glow. These enforcement actions came during heightened concern about reproductive health data privacy following the U.S. Supreme Court's 2022 decision in Dobbs v. Jackson Women's Health Organization.

See also

References

Related Articles

Wikiwand AI